Average Co-Inventor Count = 4.17
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Zymogenetics, Inc. (51 from 723 patents)
2. University of Washington (2 from 2,103 patents)
3. Ares Trading S.a. (1 from 135 patents)
4. Anergen, Inc. (1 from 17 patents)
5. National Jewish Medical Research Center (1 from 2 patents)
6. National Jewish Medical and Research Center (41 patents)
52 patents:
1. RE48370 - Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus
2. 10227415 - Methods of producing a zcytor17 heterodimeric cytokine receptor
3. 9738700 - ZCYTOR17 heterodimeric cytokine receptor
4. 9725506 - Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus
5. 9605062 - Polynucleotides encoding ZCYTOR17 ligand antibodies
6. 9346878 - Methods of treating glomerulonephritis associated with IGA nephropathy for TACI-immunoglobulin fusion proteins
7. 9212213 - ZCYTOR17 heterodimeric cytokine receptor
8. 8926957 - Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
9. 8815238 - Methods for Preparing TACI-immunoglobulin fusion proteins
10. 8784812 - Methods for treating autoimmune diseases using a TACI-Ig fusion molecule
11. 8778344 - Method of treating atopic dermatitis with antibody to zcytor17 ligand
12. 8647866 - ZCYTOR17 heterodimeric cytokine receptor polynucleotides
13. 8524232 - Methods of treatment using taci-immunoglobulin fusion proteins
14. 8435745 - Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
15. 8388964 - Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells